BeOne Medicines AG (HKG:6160)
207.80
+3.00 (1.46%)
Nov 26, 2025, 1:35 PM HKT
BeOne Medicines AG Employees
BeOne Medicines AG had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
3.54M HKD
Profits / Employee
23.34K HKD
Market Cap
288.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11,000 | 400 | 3.77% |
| Dec 31, 2023 | 10,600 | 1,600 | 17.78% |
| Dec 31, 2022 | 9,000 | 1,000 | 12.50% |
| Dec 31, 2021 | 8,000 | 2,700 | 50.94% |
| Dec 31, 2020 | 5,300 | 1,800 | 51.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| WuXi Biologics | 12,575 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
| WuXi XDC Cayman | 2,041 |
BeOne Medicines AG News
- 19 days ago - BeiGene Non-GAAP EPADS of $2.65, revenue of $1.4B beats by $40M - Seeking Alpha
- 20 days ago - BeiGene Q3 2025 Earnings Preview - Seeking Alpha
- 3 months ago - BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up - Benzinga
- 3 months ago - A Glimpse of BeiGene's Earnings Potential - Benzinga
- 4 months ago - BeiGene's Earnings: A Preview - Benzinga
- 4 months ago - BeiGene Q2 2025 Earnings Preview - Seeking Alpha
- 5 months ago - Glenmark Pharmaceuticals launches TEVIMBRA in India for advanced lung and esophageal cancer treatment - Business Upturn
- 6 months ago - Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval - Business Upturn